In view of the dispersed data related to CX3CL1/CX3CR1 and ischemic stroke it is difficult to judge the neuroprotective role of CX3CL1/CX3CR1 signaling and the future possibility to manipulate this pathway pharmaceutically to reduce the sequel of stroke. This evidence concerns the gene CX3CR1 and ischemic stroke.